Skip to main content

Posts

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Implementation Trial In patieNts With rEnal failuRe and diAbetes for Major Adverse reNal and Cardiovascular Events

Published on: 2026-06-09T04:00:00Z Conditions : Diabetes; Renal Failure , Chronic Interventions : Other: Health-related messages Sponsors : Nantes University Hospital; Hospices Civils de Lyon; University Hospital, Toulouse; University Hospital, Tours; Biogroup Laboratoire de biologie médicale; Santé publique France-InVS (Institut National de Veille sanitaire) Not yet recruiting https://ift.tt/ZRbT1Jt

Latest Posts

New diabetes clinical trial: A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec

New diabetes clinical trial: A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)

New diabetes clinical trial: Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes

New diabetes clinical trial: BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

New diabetes clinical trial: To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition

New diabetes clinical trial: SAPI vs SASI in the Management of Morbid Obesity

New diabetes clinical trial: tSCS and AR Training on QoL and Physical Activity in Diabetic Neuropathy Patients

New diabetes clinical trial: HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

New diabetes clinical trial: Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients

New diabetes clinical trial: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting